Trieu Vuong bought OTLC
June 17, 2026 · Form 4 insider transaction
Trieu Vuong bought 239,759 shares of Oncotelic Therapeutics, Inc. at $0.04 per share, a transaction worth $10.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
239,759
Price
$0.04
Total value
$10.7K
InsiderTrieu Vuong
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 17, 2026
Filing dateJune 17, 2026
Shares owned after93,629,319
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On June 15, 2026, Dr. Vuong Trieu purchased 96,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.05. Further, on June 17, 2026, Dr. Vuong Trieu purchased 239,759 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.0446.